{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:15:41Z","timestamp":1793049341176,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.prrv.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T08:06:14Z","timestamp":1705824374000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS\/CFSPID subjects: A systematic review"],"prefix":"10.1016","volume":"51","author":[{"given":"Vito","family":"Terlizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Manti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe F.","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chiappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic fibrosis: current therapeutic targets and future approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/archdischild-2019-316882","article-title":"NICE guidance on diagnosis and management of cystic fibrosis","volume":"106","author":"Dayasiri","year":"2021","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"Suppl 2","key":"10.1016\/j.prrv.2024.01.001_b0015","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","article-title":"ECFS Diagnostic Network Working Group. ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria","volume":"21","author":"Castellani","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.prrv.2024.01.001_b0025","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/archdischild-2011-300449","article-title":"Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre","volume":"96","author":"Dijk","year":"2011","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ppul.26279","article-title":"Variation in cystic fibrosis newborn screening algorithms in the United States","volume":"58","author":"Rehani","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2022.09.012","article-title":"European CF Society Neonatal Screening Working Group (ECFS NSWG). European survey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance","volume":"22","author":"Munck","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcf.2016.12.012","article-title":"The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe","volume":"16","author":"Barben","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2009.01.004","article-title":"European best practice guidelines for cystic fibrosis neonatal screening","volume":"8","author":"Castellani","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1542\/peds.23.3.545","article-title":"A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis","volume":"23","author":"Gibson","year":"1959","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2024.01.001_b0055","article-title":"Diagnosis of Cystic Fibrosis in Screened Populations","author":"Farrell","year":"201718133","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.001_b0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00431-001-0910-8","article-title":"Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations","volume":"161","author":"Padoan","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"3 Suppl","key":"10.1016\/j.prrv.2024.01.001_b0065","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jpeds.2005.08.017","article-title":"Diagnostic dilemmas resulting from the immunoreactive trypsinogen\/DNA cystic fibrosis newborn screening algorithm","volume":"147","author":"Parad","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.prrv.2024.01.001_b0070","doi-asserted-by":"crossref","unstructured":"C. Fibrosis Foundation; Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, et al. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond J Pediatr. 155 6 Suppl 2009 S106 S116 10.1016\/j.jpeds.2009.09.003.","DOI":"10.1016\/j.jpeds.2009.09.003"},{"key":"10.1016\/j.prrv.2024.01.001_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.09.066","article-title":"Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis","author":"Ren","year":"2017","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.001_b0080","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcf.2021.03.015","article-title":"A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS\/CFSPID) in six Italian centres","volume":"20","author":"Terlizzi","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.001_b0085","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","volume":"20","author":"Barben","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0090","first-page":"177","article-title":"A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening","volume":"10","author":"Tosco","year":"2023","journal-title":"Children (Basel)"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jcf.2022.12.002","article-title":"High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results","volume":"22","author":"Ginsburg","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijns5020023","article-title":"Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study","volume":"5","author":"Johnson","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.prrv.2024.01.001_b0105","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ 2021; 372 :n71 doi:10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"issue":"8114","key":"10.1016\/j.prrv.2024.01.001_b0110","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(79)90825-0","article-title":"Dried-blood spot screening for cystic fibrosis in the newborn","volume":"1","author":"Crossley","year":"1979","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns6010018","article-title":"Newborn Screening for CF across the Globe-Where Is It Worthwhile?","volume":"6","author":"Scotet","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.001_b0120","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jpeds.2006.07.026","article-title":"Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening","volume":"149","author":"Sontag","year":"2006","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0125","doi-asserted-by":"crossref","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12887-019-1756-4","article-title":"Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis","volume":"19","author":"Ooi","year":"2019","journal-title":"BMC Pediatr"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.001_b0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.24953\/turkjped.2019.04.006","article-title":"Two years of newborn screening for cystic fibrosis in Turkey: \u00c7ukurova experience","volume":"61","author":"\u015ea\u015fih\u00fcseyino\u011flu","year":"2019","journal-title":"Turk J Pediatr"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0140","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051740","article-title":"Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age","volume":"148","author":"Gonska","year":"2021","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/archdischild-2021-323549","article-title":"Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis","volume":"108","author":"Fingerhut","year":"2023","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.001_b0150","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ppul.24634","article-title":"Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening","volume":"55","author":"Munck","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.001_b0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cge.12711","article-title":"Refining the continuum of CFTR-associated disorders in the era of newborn screening","volume":"89","author":"Levy","year":"2016","journal-title":"Clin Genet"},{"issue":"12","key":"10.1016\/j.prrv.2024.01.001_b0160","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/diagnostics10121080","article-title":"Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?","volume":"10","author":"Terlizzi","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","article-title":"Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice","volume":"7","author":"Castellani","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2018.09.002","article-title":"Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His","volume":"18","author":"Keenan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.prrv.2024.01.001_b0175","doi-asserted-by":"crossref","first-page":"1127659","DOI":"10.3389\/fped.2023.1127659","article-title":"Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis\/CFTR related metabolic syndrome","volume":"11","author":"Gunnett","year":"2023","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.001_b0180","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jcf.2022.04.020","article-title":"Clinical outcomes of a large cohort of individuals with the F508del\/5T;TG12 CFTR genotype","volume":"21","author":"Tosco","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.001_b0185","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ppul.26323","article-title":"Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences","volume":"58","author":"Tosco","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.001_b0190","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ppul.26296","article-title":"Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS\/CFSPID to CF reclassification","volume":"58","author":"Salinas","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.001_b0195","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3476(95)70157-5","article-title":"Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations","volume":"127","author":"Wilschanski","year":"1995","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2013.09.007","article-title":"Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data","volume":"13","author":"Accurso","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0205","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/ppul.25296","article-title":"Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants","volume":"56","author":"Bauer","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0210","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jcf.2021.06.012","article-title":"When CFSPID becomes CF","volume":"21","author":"Ginsburg","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.001_b0215","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2019.04.002","article-title":"Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany","volume":"18","author":"Terlizzi","year":"2019","journal-title":"Italy J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcf.2017.11.002","article-title":"The relationship between sweat chloride levels and mortality in cystic fibrosis varies by individual genotype","volume":"17","author":"Espel","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.001_b0225","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ppul.24721","article-title":"Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: Is there a risk of increasing sweat chloride over time?","volume":"55","author":"Terlizzi","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0230","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jcf.2021.12.010","article-title":"Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis","volume":"21","author":"Hatton","year":"2022","journal-title":"Moving forward J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0235","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcf.2023.04.018","article-title":"Variability of the sweat test in children with Cystic Fibrosis previously CRMS\/CFSPID: A retrospective monocenter experience","volume":"22","author":"Terlizzi","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.001_b0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/ijns9030041","article-title":"Comparison between Gibson-Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis","volume":"9","author":"Dolce","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0245","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jcf.2019.10.014","article-title":"Risk factors for progression of structural lung disease in school-age children with cystic fibrosis","volume":"19","author":"Svedberg","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0250","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1542\/peds.2014-3698","article-title":"Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening","volume":"135","author":"Ren","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcf.2022.07.007","article-title":"Different management approaches and outcome for infants with an inconclusive diagnosis following newborn screening for cystic fibrosis (CRMS\/CFSPID) and Pseudomonas aeruginosa isolation","volume":"22","author":"Dolce","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.01.052","article-title":"Long-term outcomes of children with intermediate sweat chloride values in infancy","volume":"166","author":"Groves","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.prrv.2024.01.001_b0265","first-page":"1","article-title":"Techniques of assessing small airways dysfunction","author":"McNulty","year":"2014","journal-title":"Eur Clin Respir J"},{"issue":"11","key":"10.1016\/j.prrv.2024.01.001_b0270","first-page":"1625","article-title":"Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series","volume":"9","author":"Terlizzi","year":"2022","journal-title":"Children (Basel)"},{"issue":"12","key":"10.1016\/j.prrv.2024.01.001_b0275","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/ppul.25071","article-title":"Lung clearance index: A new measure of late lung complications of cancer therapy in children","volume":"55","author":"Parisi","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00408-019-00307-3","article-title":"Abnormal Lung Clearance Index in Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) Children with Otherwise Normal FEV1","volume":"198","author":"Kasi","year":"2020","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.001_b0285","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcf.2015.03.006","article-title":"Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants","volume":"14","author":"Salinas","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.prrv.2024.01.001_b0290","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1164\/rccm.201205-0922OC","article-title":"\u03b2-adrenergic sweat secretion as a diagnostic test for cystic fibrosis","volume":"186","author":"Quinton","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41390-019-0503-8","article-title":"Image-based \u03b2-adrenergic sweat rate assay captures minimal cystic fibrosis transmembrane conductance regulator function","volume":"87","author":"Salinas","year":"2020","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0300","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00209-2022","article-title":"Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test","volume":"60","author":"Nguyen-Khoa","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.001_b0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ppul.26179","article-title":"\u03b2-adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?","volume":"58","author":"Zampoli","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.01.001_b0310","first-page":"23","article-title":"An innovative strategy for personalised medicine in a CFSPID case that evolved with time","volume":"47","author":"Twynam-Perkins","year":"2023","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.001_b0315","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ppul.26209","article-title":"Detection of disease-causing CFTR variants in state newborn screening programs","volume":"58","author":"McGarry","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.01.001_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.07.010","article-title":"Hidden CFSPID in CF patient registries? The Italian CF Registry experience","author":"Terlizzi","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.prrv.2024.01.001_b0325","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1002\/ppul.25683","article-title":"Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/CF screen-positive, inconclusive diagnosis","volume":"56","author":"Terlizzi","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.01.001_b0330","doi-asserted-by":"crossref","DOI":"10.1007\/s00431-023-05359-5","article-title":"Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS\/CFSPID subjects in preschool and school age","author":"Fevola","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"12","key":"10.1016\/j.prrv.2024.01.001_b0335","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.arcped.2017.07.015","article-title":"Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening","volume":"24","author":"Sermet-Gaudelus","year":"2017","journal-title":"Arch Pediatr"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:43:11Z","timestamp":1733161391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054224000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":67,"alternative-id":["S1526054224000022"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2024.01.001","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS\/CFSPID subjects: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}